Evidence map›Paper›PMID 27541486›Full record

ArticleJournal of materials science. Materials in medicine2016

Promotion of adhesion and proliferation of endothelial progenitor cells on decellularized valves by covalent incorporation of RGD peptide and VEGF.

Jianliang Zhou, Jingli Ding, Bin'en Nie, Shidong Hu, Zhigang Zhu, Jia Chen, Jianjun Xu, Jiawei Shi, Nianguo Dong

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. New substrates for stem cell control.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2018
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Jianliang ZhouDepartment of Cardiothoracic Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China. zhoujianliang2010@163.com.
Jingli DingDepartment of Gastroenterology, the Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Bin'en NieShanghai Key Laboratory of Orthopedic Implants, Department of Orthopedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Shidong HuDepartment of Cardiothoracic Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Zhigang ZhuDepartment of Cardiothoracic Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Jia ChenDepartment of Cardiothoracic Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Jianjun XuDepartment of Cardiothoracic Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Jiawei ShiDepartment of Cardiovascular Surgery, the Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430022, China.
Nianguo DongDepartment of Cardiovascular Surgery, the Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430022, China. dongnianguo2013@163.com.
Nanchang University · CNSecond Affiliated Hospital of Nanchang University · CNHuazhong University of Science and Technology · CNShanghai Jiao Tong University · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue engineered heart valve is a promising alternative to current heart valve surgery, for its capability of growth, repair, and remodeling. However, extensive development is needed to ensure tissue compatibility, durability and antithrombotic potential. This study aims to investigate the biological effects of multi-signal composite material of polyethyl glycol-cross-linked decellularized valve on adhesion and proliferation of endothelial progenitor cells. Group A to E was decellularized valve leaflets, composite material of polyethyl glycol-cross-linked decellularized valves leaflets, vascular endothelial growth factor-composite materials, Arg-Gly-Asp peptide-composite materials and multi-signal modified materials of polyethyl glycol-cross-linked decellularized valve leaflets, respectively. The endothelial progenitor cells were seeded for each group, cell adhesion and proliferation were detected and neo-endothelium antithrombotic function of the multi-signal composite materials was evaluated. At 2, 4, and 8 h after the seeding, the cell numbers and 3H-TdR incorporation in group D were the highest. At 2, 4, and 8 days after the seeding, the cell numbers and 3H-TdR incorporation were significantly higher in groups C, D, and E compared with groups A and B (P < 0.05) and cell numbers and the expression of t-PA and eons in the neo-endothelium were quite similar to those in the human umbilical vein endothelial cells at 2, 4, and 8 days after the seeding. The Arg-Gly-Asp- peptides (a sequential peptide composed of arginine (Arg), glycine (Gly) and aspartic acid (Asp)) and VEGF-conjugated onto the composite material of PEG-crosslinked decellularized valve leaflets synergistically promoted the adhesion and proliferation of endothelial progenitor cells on the composite material, which may help in tissue engineering of heart valves.

Indexed as

AnimalsArginineAspartic AcidCell AdhesionCell ProliferationCross-Linking ReagentsEdetic AcidFibrinolytic AgentsGlycineHeart ValvesHumansHuman Umbilical Vein Endothelial CellsLipoproteins, LDLMaleOligopeptidesPolyethylene GlycolsArgininearginyl-glycyl-aspartic acidAspartic AcidCross-Linking ReagentsEdetic AcidFibrinolytic AgentsGlycineLipoproteins, LDLOligopeptidesPolyethylene GlycolsTissue Plasminogen ActivatorVascular Endothelial Growth Factor A

Identifiers

PMID27541486
OpenAlexW2508742657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.